Showing results (851-860 of 11,113) with videos related to

Sort By:
Pageof 1,112
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Potential Application of Small Interfering RNA in Gastro-Intestinal TumorsPasquale Losurdo, Nicolò de Manzini, Silvia Palmisano, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Valorisation of the Inhibitory Potential of Fresh and Dried Fruit Extracts of Prunus spinosa L. towards Carbohydrate Hydrolysing Enzymes, Protein Glycation, Multiple Oxidants and Oxidative Stress-Induced Changes in Human Plasma ConstituentsAnna Magiera, Joanna Kołodziejczyk-Czepas, Karolina Skrobacz, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Overview on Strategies and Assays for Antibiotic DiscoveryAnika Rütten, Teresa Kirchner, Ewa Maria Musiol-Kroll
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System DrugsJunbo Zhu, Yabin Duan, Delong Duo, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress ComplexSewar Alkhashrom, Jintawee Kicuntod, Katharina Stillger, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Exploring the Underlying Mechanism of Ren-Shen-Bai-Du Powder for Treating Inflammatory Bowel Disease Based on Network Pharmacology and Molecular DockingNi Jin, Yao Liu, Peiyu Xiong, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-onesAzizah M Malebari, Gabriela Duffy Morales, Brendan Twamley, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Fmoc-Diphenylalanine Hydrogels: Optimization of Preparation Methods and Structural InsightsCarlo Diaferia, Elisabetta Rosa, Giancarlo Morelli, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In VivoBennet Y Weber, Gábor B Brenner, Bernadett Kiss, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE-/- MiceMing Gao, Xing Heng, Jing Jin, et al.
Pageof 1,112